With new data on petosemtamab set to be presented at the European Society for Medical Oncology Asia Congress, Merus believes ...

Coherus sells Udenyca franchise for up to $558.4 million, shifts focus to immuno-oncology R&D, and plans clinical trials in ...

Perioperative chemotherapy may be underused in patients with stage II-III esophageal cancer, according to researchers.

It’s hard not to reminisce about Christmases past and have thoughts of thanksgiving during this special time of year. Paula ...

A biopsy reveals squamous cell carcinoma (SCC) in situ. What should be the next steps in the patient's evaluation and management? After the initial consultation, the patient's biopsy specimen was ...

Primary squamous cell carcinoma of the prostate is a rare entity, with limited documented cases in the medical literature. Herein, we present a case of primary prostatic squamous cell carcinoma in a ...

BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company that intends to change its name to BeOne ...

No filter, high-puff frequency, higher quantities of nicotine and tar in bidi The Tribune, now published from Chandigarh, ...

The KOL event will take place on Tuesday, December 17, 2024, at 12 p.m. ET and panel participants include: The event will be moderated by Kirk Shepard, M.D., PDS Biotech’s Chief Medical Officer. Date: ...

The FDA has approved 43 novel drugs so far this year (January-November), compared to 52 during the same period last year. As we step ...